Skip to Content
  1. All Products
  2. Year
  3. Zheijiang Guobang Pharmaceuticals, China, 2025
-
Zheijiang Guobang Pharmaceuticals, China, 2025

Zheijiang Guobang Pharmaceuticals, China, 2025

https://myauditor.nl/web/image/product.template/1071/image_1920?unique=5617e63

GMP Audit Report

Company
Chifeng Pharmaceutical Co Ltd

Product(s)
Griseofulvin, Oxytetracycline 2AQ

Country
China

Audit Year
2025


0.00 € 0.0 EUR 0.00 €

0.00 €

This combination does not exist.

Request Quotation
Doxycyclin Hyclate marbofloxacin tulathromycin

 

Share